Brief: Symbio Pharmaceuticals initiated Phase 1 Study in Japan for Oral Treakisym in patients with progressive solid tumors

SymBio Pharmaceuticals

21/01/2018 23:31

Jan 21 (Reuters) - Symbio Pharmaceuticals Ltd  4582.T : 
    * HAS INITIATED A PHASE 1 STUDY IN JAPAN FOR ORAL TREAKISYM 
IN 
PATIENTS WITH PROGRESSIVE SOLID TUMORS 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nBw1FLGkma 
Further company coverage:  4582.T  
 
 ((Bangalore.newsroom@thomsonreuters.com ;))